Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohnʼs disease: A randomized, double-blind, placebo-controlled pilot study
Authors:
- Uma MahadevanUMUma Mahadevan
- Brian G. FeaganBFBrian G. Feagan
- Cindy WongCWCindy Wong
- Alan CockeramACAlan Cockeram
- Alain BittonABAlain Bitton
- Charles N. BernsteinCBCharles N. Bernstein
- William J. SandbornWSWilliam J. Sandborn
- 1 January 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 15 (1) , 17-24
Abstract
Although metronidazole and ciprofloxacin are used to treat perianal Crohn's disease (CD), no placebo-controlled trials have been performed. We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of metronidazole and ciprofloxacin in patients with perianal CD. Twenty-five patients with CD and actively draining perianal fistulas were randomized to receive ciprofloxacin 500 mg, metronidazole 500 mg, or placebo twice daily for 10 weeks. Remission and response of perianal fistulas were defined as closure of all fistulas and closure of at least 50% of fistulas that were draining at baseline, respectively. The primary endpoint was remission at 10 weeks. Ten patients were randomized to ciprofloxacin, 7 to metronidazole, and 8 to placebo. Remission at week 10 occurred in 3 patients (30%) treated with ciprofloxacin, no patients (0%) treated with metronidazole, and 1 patient (12.5%) treated with placebo (P = 0.41). Response at week 10 occurred in 4 patients (40%) treated with ciprofloxacin, 1 patient (14.3%) treated with metronidazole, and 1 patient (12.5%) treated with placebo (P = 0.43). Termination of the trial prior to week 10 occurred in 1 patient (10%) treated with ciprofloxacin, 5 patients (71.4%) treated with metronidazole, and 1 patient (12.5%) treated with placebo (P < 0.02). No serious adverse events occurred. Remission and response occurred more frequently in patients treated with ciprofloxacin but the differences were not significant in this pilot study. Ciprofloxacin was well tolerated.Keywords
This publication has 33 references indexed in Scilit:
- Are Perineal and Luminal Fistulas Associated in Crohn’s Disease? A Population-Based StudyClinical Gastroenterology and Hepatology, 2006
- Predictors of Crohn’s DiseaseGastroenterology, 2006
- Crohn’s disease in Stockholm County during 1990-2001: An epidemiological updateWorld Journal of Gastroenterology, 2006
- AGA technical review on perianal Crohn’s diseaseGastroenterology, 2003
- Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's diseaseAmerican Journal of Gastroenterology, 2002
- The natural history of fistulizing Crohn's disease in Olmsted County, MinnesotaGastroenterology, 2002
- Clinical course of colorectal Crohn's disease: A 35-year follow-up study of 507 patientsGastroenterology, 1998
- Favorable effect of 6-Mercaptopurine on fistulae of Crohn's diseaseDigestive Diseases and Sciences, 1985
- Anal fistulas in Crohn's diseaseBritish Journal of Surgery, 1981
- Anal complications in Crohn's diseaseDiseases of the Colon & Rectum, 1981